Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Dauner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the American Pharmacists Association : Japha|February 6, 2021
Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemicDaniel G Dauner, Kim Nichols Dauner
Expert Opinion on Drug Safety|February 8, 2021
Comparing the use of individual and composite terms to evaluate adverse drug event disproportionality: a focus on glucagon-like peptide-1 receptor agonists and diabetic retinopathyDaniel G Dauner, Joel F Farley
Southern Medical Journal|February 3, 2007
Statewide sentinel surveillance for antibiotic nonsusceptibility among streptococcus pneumoniae isolates in South Carolina, 2003-2004Daniel G Dauner, Dixie F Roberts, George S Kotchmar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 3, 2010
Ceftobiprole: A novel, broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureusDaniel G Dauner, Robert E Nelson, Donna C Taketa
Research in Social & Administrative Pharmacy : RSAP|December 9, 2019
FDA's Unimproved Enforcement of Postmarketing Requirements and Commitments: Implications for Providers and PatientsDaniel G Dauner, Kim Nichols Dauner, Annalisa L H Peterson
Journal of Managed Care & Specialty Pharmacy|September 20, 2022
Direct-acting antiviral retreatment patterns for hepatitis CShaquib Al Hasan, Daniel G Dauner, Abhijeet Rajpurohit, et al.
Southern Medical Journal|October 23, 2003
Laboratory survey of antibiotic nonsusceptibility among Streptococcus pneumoniae isolates in South Carolina, 1998 versus 2000Daniel G Dauner, James J Gibson, Dixie F Roberts, et al.
Therapeutic Advances in Drug Safety|December 29, 2023
Evaluation of four machine learning models for signal detectionDaniel G Dauner, Eleazar Leal, Terrence J Adam, et al.
Expert Opinion on Drug Safety|February 17, 2023
Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting systemDaniel G Dauner, Rui Zhang, Terrence J Adam, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the American Pharmacists Association : Japha|February 6, 2021
Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemicDaniel G Dauner, Kim Nichols Dauner
Expert Opinion on Drug Safety|February 8, 2021
Comparing the use of individual and composite terms to evaluate adverse drug event disproportionality: a focus on glucagon-like peptide-1 receptor agonists and diabetic retinopathyDaniel G Dauner, Joel F Farley
Southern Medical Journal|February 3, 2007
Statewide sentinel surveillance for antibiotic nonsusceptibility among streptococcus pneumoniae isolates in South Carolina, 2003-2004Daniel G Dauner, Dixie F Roberts, George S Kotchmar
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 3, 2010
Ceftobiprole: A novel, broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureusDaniel G Dauner, Robert E Nelson, Donna C Taketa
Research in Social & Administrative Pharmacy : RSAP|December 9, 2019
FDA's Unimproved Enforcement of Postmarketing Requirements and Commitments: Implications for Providers and PatientsDaniel G Dauner, Kim Nichols Dauner, Annalisa L H Peterson
Journal of Managed Care & Specialty Pharmacy|September 20, 2022
Direct-acting antiviral retreatment patterns for hepatitis CShaquib Al Hasan, Daniel G Dauner, Abhijeet Rajpurohit, et al.
Southern Medical Journal|October 23, 2003
Laboratory survey of antibiotic nonsusceptibility among Streptococcus pneumoniae isolates in South Carolina, 1998 versus 2000Daniel G Dauner, James J Gibson, Dixie F Roberts, et al.
Therapeutic Advances in Drug Safety|December 29, 2023
Evaluation of four machine learning models for signal detectionDaniel G Dauner, Eleazar Leal, Terrence J Adam, et al.
Expert Opinion on Drug Safety|February 17, 2023
Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting systemDaniel G Dauner, Rui Zhang, Terrence J Adam, et al.
Pageof 1